- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD8931
Total 96 results
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)Korea, Republic of, United Kingdom, Australia, United States, Spain
-
AstraZenecaTerminatedBreast NeoplasmKorea, Republic of, Germany, Taiwan
-
AstraZenecaTerminated
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelTerminated
-
AstraZenecaParexelCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedPolycystic Ovary Syndrome (PCOS), Female Endocrine DisorderUnited States, United Kingdom, Germany
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
AstraZenecaParexelCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States
-
AstraZenecaCompletedModerate to Severe COPDSweden, Bulgaria, Poland, Denmark, Slovakia
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedAsthmaUnited States, Germany, United Kingdom
-
AstraZenecaTerminatedHeart FailureDenmark, Finland, Netherlands, United States, Sweden
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, Germany, Netherlands
-
AstraZenecaCompletedOne Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids (OLIVE)AsthmaPoland, Argentina, Brazil, Costa Rica
-
AstraZenecaCompletedAsthma PatientsUnited States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Completed
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited States
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaParexelCompleted
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaParexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.CompletedChronic Obstructive Pulmonary Disease - COPDUnited Kingdom
-
AstraZenecaCompletedHealthy | Postmenopausal | Surgically Sterile WomenSweden
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
AstraZenecaCompletedHyperlipidaemiaDenmark, Netherlands, Spain, Czechia, United States, Slovakia, Hungary, Poland
-
AstraZenecaRecruitingHepatic ImpairmentUnited States
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease COPDGermany, United Kingdom
-
Johns Hopkins UniversityAstraZenecaCompleted
-
AstraZenecaRecruitingCOVID-19 | SARS-CoV-2 InfectionUnited States